vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Celsius Holdings, Inc. (CELH). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $721.6M, roughly 1.3× Celsius Holdings, Inc.). Celsius Holdings, Inc. runs the higher net margin — 3.4% vs 0.7%, a 2.7% gap on every dollar of revenue. On growth, Celsius Holdings, Inc. posted the faster year-over-year revenue change (117.2% vs 42.9%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-130.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 42.4%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Celsius Holdings, Inc. is an American company that produces a range of fitness and energy drinks under the brand name Celsius. The company's products are marketed as healthy, to which the CEO attributes the brand's success.
ASTH vs CELH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $721.6M |
| Net Profit | $6.6M | $24.7M |
| Gross Margin | — | 47.4% |
| Operating Margin | 1.9% | 3.6% |
| Net Margin | 0.7% | 3.4% |
| Revenue YoY | 42.9% | 117.2% |
| Net Profit YoY | 184.4% | 231.1% |
| EPS (diluted) | $0.12 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $721.6M | ||
| Q3 25 | $956.0M | $725.1M | ||
| Q2 25 | $654.8M | $739.3M | ||
| Q1 25 | $620.4M | $329.3M | ||
| Q4 24 | $665.2M | $332.2M | ||
| Q3 24 | $478.7M | $265.7M | ||
| Q2 24 | $486.3M | $402.0M | ||
| Q1 24 | $404.4M | $355.7M |
| Q4 25 | $6.6M | $24.7M | ||
| Q3 25 | $373.0K | $-61.0M | ||
| Q2 25 | $9.4M | $99.9M | ||
| Q1 25 | $6.7M | $44.4M | ||
| Q4 24 | $-7.8M | $-18.9M | ||
| Q3 24 | $16.1M | $6.4M | ||
| Q2 24 | $19.2M | $79.8M | ||
| Q1 24 | $14.8M | $77.8M |
| Q4 25 | — | 47.4% | ||
| Q3 25 | — | 51.3% | ||
| Q2 25 | — | 51.5% | ||
| Q1 25 | — | 52.3% | ||
| Q4 24 | — | 50.2% | ||
| Q3 24 | — | 46.0% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | 51.2% |
| Q4 25 | 1.9% | 3.6% | ||
| Q3 25 | 2.0% | -11.0% | ||
| Q2 25 | 3.1% | 19.3% | ||
| Q1 25 | 3.3% | 15.8% | ||
| Q4 24 | 0.1% | -5.6% | ||
| Q3 24 | 5.9% | -1.2% | ||
| Q2 24 | 6.2% | 23.4% | ||
| Q1 24 | 7.5% | 23.4% |
| Q4 25 | 0.7% | 3.4% | ||
| Q3 25 | 0.0% | -8.4% | ||
| Q2 25 | 1.4% | 13.5% | ||
| Q1 25 | 1.1% | 13.5% | ||
| Q4 24 | -1.2% | -5.7% | ||
| Q3 24 | 3.4% | 2.4% | ||
| Q2 24 | 3.9% | 19.8% | ||
| Q1 24 | 3.7% | 21.9% |
| Q4 25 | $0.12 | $0.04 | ||
| Q3 25 | $0.01 | $-0.27 | ||
| Q2 25 | $0.19 | $0.33 | ||
| Q1 25 | $0.14 | $0.15 | ||
| Q4 24 | $-0.14 | $-0.10 | ||
| Q3 24 | $0.33 | $0.00 | ||
| Q2 24 | $0.40 | $0.28 | ||
| Q1 24 | $0.31 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $398.9M |
| Total DebtLower is stronger | — | $676.9M |
| Stockholders' EquityBook value | $779.3M | $1.2B |
| Total Assets | $2.2B | $5.1B |
| Debt / EquityLower = less leverage | — | 0.57× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $398.9M | ||
| Q3 25 | $463.4M | $806.0M | ||
| Q2 25 | $342.1M | $615.2M | ||
| Q1 25 | $260.9M | $977.3M | ||
| Q4 24 | $290.8M | $890.2M | ||
| Q3 24 | $350.3M | $903.7M | ||
| Q2 24 | $327.7M | $903.2M | ||
| Q1 24 | $337.3M | $879.5M |
| Q4 25 | — | $676.9M | ||
| Q3 25 | — | $870.5M | ||
| Q2 25 | — | $871.9M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $779.3M | $1.2B | ||
| Q3 25 | $775.5M | $1.2B | ||
| Q2 25 | $765.5M | $1.3B | ||
| Q1 25 | $745.4M | $443.1M | ||
| Q4 24 | $712.7M | $399.9M | ||
| Q3 24 | $704.6M | $423.6M | ||
| Q2 24 | $678.9M | $415.8M | ||
| Q1 24 | $653.5M | $338.2M |
| Q4 25 | $2.2B | $5.1B | ||
| Q3 25 | $2.2B | $5.3B | ||
| Q2 25 | $1.4B | $3.8B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.3B | $1.7B | ||
| Q2 24 | $1.3B | $1.7B | ||
| Q1 24 | $1.2B | $1.6B |
| Q4 25 | — | 0.57× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.69× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $-119.4M |
| Free Cash FlowOCF − Capex | $-6.0M | $-130.0M |
| FCF MarginFCF / Revenue | -0.6% | -18.0% |
| Capex IntensityCapex / Revenue | 0.3% | 1.5% |
| Cash ConversionOCF / Net Profit | -0.44× | -4.83× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $323.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $-119.4M | ||
| Q3 25 | $10.0M | $331.8M | ||
| Q2 25 | $90.9M | $43.7M | ||
| Q1 25 | $16.6M | $103.4M | ||
| Q4 24 | $-10.9M | $75.7M | ||
| Q3 24 | $34.0M | $12.9M | ||
| Q2 24 | $23.2M | $39.6M | ||
| Q1 24 | $6.0M | $134.6M |
| Q4 25 | $-6.0M | $-130.0M | ||
| Q3 25 | $7.4M | $321.5M | ||
| Q2 25 | $89.5M | $35.5M | ||
| Q1 25 | $13.6M | $96.4M | ||
| Q4 24 | $-13.5M | $70.3M | ||
| Q3 24 | $31.7M | $8.7M | ||
| Q2 24 | $20.4M | $30.4M | ||
| Q1 24 | $5.6M | $130.1M |
| Q4 25 | -0.6% | -18.0% | ||
| Q3 25 | 0.8% | 44.3% | ||
| Q2 25 | 13.7% | 4.8% | ||
| Q1 25 | 2.2% | 29.3% | ||
| Q4 24 | -2.0% | 21.2% | ||
| Q3 24 | 6.6% | 3.3% | ||
| Q2 24 | 4.2% | 7.6% | ||
| Q1 24 | 1.4% | 36.6% |
| Q4 25 | 0.3% | 1.5% | ||
| Q3 25 | 0.3% | 1.4% | ||
| Q2 25 | 0.2% | 1.1% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.6% | 2.3% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | -0.44× | -4.83× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 0.44× | ||
| Q1 25 | 2.48× | 2.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 2.03× | ||
| Q2 24 | 1.21× | 0.50× | ||
| Q1 24 | 0.40× | 1.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CELH
Segment breakdown not available.
